SCHEMBL1448419

SCHEMBL1448419

COC(=O)C(C)(NC(C)=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.56
MAPT P10636 2/20 0.54
ELANE P08246 2/20 0.44
KMT2A Q03164 2/20 0.44
SRC P12931 1/20 0.43
ALDH1A1 P00352 2/20 0.42
RECQL P46063 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41
CTRB1 P17538 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20608008 0.85 KCNN4 (0.51) KCNN4MAPTKMT2ASRCHDAC3
SCHEMBL8115153 0.83 ALDH1A1 (0.58) KCNN4MAPTKMT2AALDH1A1RECQL
SCHEMBL21807366 0.83 HDAC3 (0.46) KCNN4MAPTELANEKMT2AALDH1A1
SCHEMBL28250865 0.83 HDAC3 (0.46) KCNN4MAPTELANEKMT2AALDH1A1
SCHEMBL30188924 0.81 KCNN4 (0.51) KCNN4MAPTELANEKMT2ASRC
SCHEMBL28615904 0.80 KCNN4 (0.50) KCNN4MAPTKMT2ASRCALDH1A1
SCHEMBL28615903 0.80 KCNN4 (0.50) KCNN4MAPTKMT2ASRCALDH1A1
SCHEMBL23868362 0.80 KCNN4 (0.58) KCNN4MAPTELANEKMT2ASRC
SCHEMBL21484936 0.80 KCNN4 (0.58) KCNN4MAPTELANEKMT2ASRC
SCHEMBL11684190 0.80 HDAC3 (0.43) KCNN4MAPTELANEKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112824421-A Chiral phosphine-phosphoramidite ligand and preparation method and application thereof 中国科学院大连化学物理研究所 2021-05-21 CN disclosed
US-7910748-B2 Thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium FUJI XEROX CO., LTD. (JP) 2011-03-22 US disclosed
US-7902382-B2 Thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium FUJI XEROX CO., LTD. (JP) 2011-03-08 US disclosed
US-20100133995-A1 Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium FUJI XEROX CO., LTD. (JP) 2010-06-03 US disclosed
US-20100137553-A1 Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium FUJI XEROX CO., LTD. (JP) 2010-06-03 US disclosed
US-7659410-B2 Thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium FUJI XEROX CO., LTD. (JP) 2010-02-09 US disclosed
US-20070252519-A1 Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium FUJI XEROX CO., LTD. (JP) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070252519-A1 Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium ARL1, NOD1, NLRP1 KCNN4 723/4885MAPT 1563/4885ELANE 1612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.